For the past two years, UnityPoint Health Ventures—the venture capital arm of UnityPoint Health—has been investing in early-stage health care companies.
Founded in May 2019 with an initial $100 million fund, the Des Moines-based venture firm makes direct investments in healthcare companies and helps them scale and deploy their technologies across UnityPoint Health hospitals and clinics.
To…
UnityPoint Health Ventures, the venture arm of UnityPoint Health, has invested $1 million in St. Louis-based Epharmix.
Epharmix, a messaging and engagement platform for care managers, is the fourth company to be awarded by the venture fund. UnityPoint Health Ventures has also invested in Pathware, RxRevu and Coralville-based VIDA Diagnostics.
Epharmix’s evidence-based check-ins use…
Coralville-based VIDA Diagnostics today announced a $1 million investment and strategic partnership from UnityPoint Health Ventures.
UnityPoint Health and VIDA will partner to develop and commercialize VIDA's AI-powered lung analysis solutions, LungPrint, a fully automated AI-powered analysis of inspiratory chest CT scans.
"VIDA's partnership with UnityPoint Health represents a shared vision for improving care to…
West Des Moines-based health care organization UnityPoint Health announced yesterday the launch of a $100 million venture fund at the inaugural MedCity INVEST Pop Health conference in New Orleans.
The new fund, titled the UnityPoint Health Ventures Innovation Fund, will manage and direct the company's financial and strategic investment opportunities.
The fund will invest in…
